Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ATreat, the most common co-covered peer. The 6 average consequence score is above the beat benchmark of 5.2 in the same window.
Last mentioned: Aug 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ATreat, the most common co-covered peer. The 6 average consequence score is above the beat benchmark of 5.2 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. We currently track 1 Healthcare story that mention Invisalign, all published on August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Invisalign. Shared-story counts are live from our verified record — not editorial picks.
Jinan court issues first-instance judgment
The Jinan Intermediate People’s Court finds Angelalign’s MasterForce and ATreat systems infringe Align’s patent, orders cessation of use, and awards RMB 10 million in damages.
Align files ITC complaint
Align Technology files a complaint with the U.S. International Trade Commission seeking to block imports of Angelalign products.
UPC issues preliminary injunction
The Unified Patent Court orders Angelalign to stop infringing Align’s ClinCheck Live Update technology in Europe; later upheld on appeal.
Align files China patent infringement action
Align Technology files suit in the Jinan Intermediate People’s Court asserting patent CN113693748B against Angelalign’s subsidiaries.
A Chinese court ruled Angelalign’s clear-aligner systems infringe Align Technology’s extraction-gap-closure patent, ordering it to cease production and pay RMB 10 million in damages—a milestone for medtech IP enforcement in China.
Invisalign is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
